Zotarolimus is an immunosuppressant. Zotarolimus failed Abbott's primary endpoint to bring their stent/drug delivery system to market.Reference standards of Zotarolimus API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Zotarolimus-d3 [catalogue_number] => PA STI 087950 [category_ids] => ,69,71,78,70,82,98, [chemical_name] => [weight] => 969.23 [form] => C52H76D3N5O12 [cas] => NA [pslug] => zotarolimus-d3-pasti087950 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 087950
CAS :
Molecular Formula : C52H76D3N5O12
Molecular Weight : 969.23
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....